2024-05-29 | Genelux Corporation GNLX | director | 6,250 0.0264% | $4.00 | $25,000 | -14.64% | ||
2024-03-14 | Sale | Assertio Holdings, Inc. ASRT | director | 10,251 0.0106% | $1.12 | $11,463 | -9.09% | |
2023-12-13 | Sale | Genelux Corporation GNLX | director | 9,000 0.0326% | $13.22 | $118,969 | -55.41% | |
2023-05-05 | Sale | Assertio Holdings, Inc. ASRT | director | 43,143 0.0825% | $6.00 | $258,767 | -65.37% | |
2022-05-12 | Sale | Assertio Holdings, Inc. ASRT | 44,643 0.0864% | $2.36 | $105,170 | +31.56% | ||
2016-05-18 | Sale | Innoviva, Inc. INVA | director | 813 0.0007% | $10.47 | $8,512 | +5% | |
2015-06-02 | Sale | Innoviva, Inc. INVA | director | 2,438 0.0022% | $16.85 | $41,080 | -29.46% | |
2009-02-27 | Sale | Abbott Laboratories ABT | Executive Vice President | 10,454 0.0007% | $47.68 | $498,465 | +0.4% | |
2009-02-17 | Sale | Abbott Laboratories ABT | Executive Vice President | 5,565 0.0004% | $54.09 | $301,030 | -11.92% | |
2009-02-02 | Sale | Abbott Laboratories ABT | Executive Vice President | 33,642 0.0022% | $55.26 | $1.86M | -14.52% | |
2008-03-04 | Sale | Abbott Laboratories ABT | Executive Vice President | 10,096 0.0007% | $53.04 | $535,486 | +3.54% | |
2008-03-03 | Sale | Abbott Laboratories ABT | Executive Vice President | 14,638 0.0009% | $53.21 | $778,892 | +3.56% | |
2008-02-19 | Sale | Abbott Laboratories ABT | Executive Vice President | 884 <0.0001% | $56.08 | $49,577 | -0.8% | |
2007-06-01 | Sale | Abbott Laboratories ABT | Executive Vice President | 48,130 0.0031% | $56.62 | $2.73M | -2.81% | |
2007-02-15 | Sale | Abbott Laboratories ABT | Executive Vice President | 1,500 <0.0001% | $52.83 | $79,245 | +5.01% | |
2006-07-26 | Sale | Abbott Laboratories ABT | Executive Vice President | 320 <0.0001% | $47.50 | $15,200 | +12.83% | |
2006-05-01 | Sale | Abbott Laboratories ABT | Executive Vice President | 137 <0.0001% | $43.01 | $5,892 | +14.88% | |
2006-02-21 | Sale | Abbott Laboratories ABT | Executive Vice President | 458 <0.0001% | $43.70 | $20,014 | +8.84% |